GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Neurocrine Biosciences, Inc. (NBIX) [hlAlert]

Rating:
Buy NBIX
up 654.64 %

Neurocrine Biosciences, Inc. (NBIX) rated Buy with price target $20 by MKM Partners

Posted on: Friday,  Feb 7, 2014  11:25 AM ET by MKM Partners

MKM Partners rated Buy Neurocrine Biosciences, Inc. (NASDAQ: NBIX) on 02/07/2014. Previously MKM Partners rated Buy Neurocrine Biosciences, Inc. (NASDAQ: NBIX) on
08/09/2011., when the stock price was $6.13. Since then, Neurocrine Biosciences, Inc. has gained 654.65% as of 10/12/2015's recent price of $46.26.
If you would have followed the previous MKM Partners's recommendation on NBIX, you would have gained 654.64% of your investment in 1525 days.

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.

MKM Partners LLC is an institutional equity trading and research firm. MKM Partners has extensive experience in the agency execution of U.S. and international equity orders. We provide clients with timely and unbiased economic, technical, and fundamental research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/7/2014 11:25 AM Buy
None
16.33 20.00
as of 10/17/2014
1 Week up  2.44 %
1 Month up  2.06 %
3 Months up  27.69 %
1 YTD up  74.73 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2013 11:25 AM Buy
None
11.94 13.50
2/11/2013 11:25 AM Buy
None
11.26 15.00
8/9/2011 11:25 AM Buy
None
6.13 12.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy